National Federations participating in the Olympic Games
Re.: Anti-Doping rules - Olympic Games Beijing 2008 Special provisions for inhaled beta2 agonists or glucocoricosteroids
Dear Mr. President, Dear Secretary General, Please find below some specific information regarding Anti-Doping rules for the Olympic Games Beijing 2008 and special provisions for inhaled beta2 agonists or glucocoricosteroids for your consideration. 1. Anti-Doping rules for the Olympic Games Beijing 2008
The IOC is responsible for doping controls which take place during the period of the Games in Beijing 2008. IOC`s zero tolerance policy will be strengthened by a serious of measures, such as:
• denial of participation in the next Olympic Games for athletes and their
encourage who have been sanctioned for more than six month
• imposition of automatic suspensions after a positive A sample and greater
financial penalties for sports organisations and athletes
• implementation of stricter regulations related to Therapeutic Use Exemptions
The IOC plans to conduct 4.500 in- and out-of-competition tests. These tests will be performed on all substances present on the 2008 Prohibited List issued by WADA. New specific elements of the rules include:
• An athlete may be notified and tested more than once during the same day;
Athletes selected for testing will generally be notified on a no-advance notice basis;
• The fact that athletes who miss a test on two separate occasions during the
Games, or on one occasion during the Games plus twice in the 18 months beforehand, will be considered to have committed an anti-doping rule violation;
• Possession of any substance from the list of prohibited substances will constitute
a violation (previously only a selection from the prohibited list applied).
IOC Anti-Doping Rules will be applicable to the Games of the XXIX Olympiad, Beijing 2008 which will be in force in relation to the Games of the XXIX Olympiad, Beijing 2008. Please find the IOC Anti-Doping Rules on the ICF website:
The Period of the Olympic Games is defined as “the period commencing on the date of the opening of the Olympic village for the Olympic Games”, namely, 27 July 2008 up until and including the day of the closing ceremony of the Olympic Games, namely 24 August 2008. The Period of the Olympic Games is treated as an “in-competition” period. All Athletes will be subject, during the Period of the Olympic Games, to Doping Controls initiated by the IOC at any time or place with no advance warning required to be given to the Athletes. The IOC has authorised WADA to carry out Doping Controls, on behalf of the IOC, during the Period of the Olympic Games, outside of China and at non Olympic venues inside of China. 2. Special Provision for inhaled beta2 agonists or glucocoricosteroids: Athletes who wish to use authorised inhaled beta2 agonists (bronchodilator-asthma medication) or glucocorticosteroids at the 2008 Olympic Games in Beijing must submit a specific request to do so to the IOC Medical and Scientific Department using the on- line Therapeutic Use Exemption request form. This on-line Therapeutic Use Exemption request form can be found on the IOC website:
and the French version:
Please be informed that you have to log-in on this website in order to access the ATUE and GCS forms. Please note that the Certificates previously issued by the ICF are NOT valid at the Olympic Games. The deadline for the on-line Therapeutic Use Exemption is the 26th July 2008.
Please note that the on-line form allows an athlete to request permission to inhale only one short acting beta2 agonist (salbutamol or terbutaline) and/or one long acting beta2 agonist (formoterol or salmeterol). These applications will be examined by a group of independent experts and the doctor in charge of the request plus the respective NOC chief physician will be informed in writing of the decision. Those athletes, who received an authorisation at the Games in Athens or Turin, will only have to complete the first part of the online application form. Please be aware that for any athlete who has not received an authorisation from the IOC Medical Commission to inhale a beta2 agonist(s), or who has not respected an approval granted to use any of these substances, the result of the doping control will be considered as an adverse analytical finding. Please find further information concerning Beta2 adrenoceptor agonists and the Olympic Games in Beijing on the ICF website:
Please do not hesitate to contact us for further information.
December 2011 Northeast Integrated Geriatrics Care Supporting Primary Care in Long-term Care Settings Author: Natalie Truesdell, MPH, MBA Northeast Integrated Geriatrics Care | 1 Introduction Between 2007 and 2009, as part of its statewide Integration Initiative, the Maine Health Access Foundation (MeHAF) funded 24 Clinical Implementation and 19 Planning or Syst
FICA REQUIREMENTS (ACCOUNT OPENING DOCUMENTATION REQUIRED) NB: ALL documents must be ORIGINALS or certified copies with ORIGINAL CERTIFIED stamp INDIVIDUALS Proof of Identity document Proof of Physical address in Client’s name (e.g. utility account showing the Physical address) NOT OLDER THAN 3 MONTHS Proof of Banking details in Client’s name (e.g
